Global Genome Engineering Market: Snapshot
The increasing interest of pharmaceutical and biotechnology companies in the development of new treatments and investments in genome research has led to an increase in genome research activities globally. Technological advancements and research programs are being undertaken in the field of genome engineering owing to the rising demand for synthetic genes through genetic mutation. This factor is expected to significantly boost the global genome engineering market in the upcoming years.
The use of genome engineering technology in a wide range of applications such as crop improvement is likely to provide lucrative opportunities to companies operating in the global genome engineering market. However, strict regulatory framework regarding approval of genetic mutation projects and negative public perception about genetic mutation is likely to impede the adoption of genome engineering among various sectors and medical and research organizations.
The global genome engineering market is projected to expand at a CAGR of 14.2% between 2015 and 2023. The global genome engineering market is estimated to reach a valuation of US$7.21 bn by the end of 2023 from a market worth US$2.30 bn in 2015.
North America to Hold Largest Revenue Share in Global Genome Engineering Market
Owing to the increasing research and development activities in the U.S., North America is expected to witness a substantial increase in its revenue share in the global genome engineering market. The North America market for genome engineering was valued at US$1.27 bn in 2015 followed by Europe and Rest of World. The rising demand for studies regarding ethical, legal, and social implications of genome engineering has led to an increase in genome engineering activities in the region.
Europe held the second largest share in terms of revenue in the global genome engineering market. The increasing investment by the European Commission in synthetic biology and research into its implications is the major driving force behind the growth of the genome engineering market in the region. However, Asia Pacific is expected to emerge as the region exhibiting the fastest growth owing to factors such as the rising government investment in genome engineering activities and increasing focus by market players on technological advancements.
Pharmaceutical and Biotechnology Companies to Emerge as Largest End-use Segment
Based on application, pharmaceutical and biotechnology companies accounted for 58% of the overall global revenue in 2014. Numerous applications of genome engineering in drug discovery and therapeutics contributed to the high growth of the segment. Moreover, the wide therapeutic use of genome engineering in the pharmaceutical industry is likely to drive its adoption in the coming years. The development of therapeutics models in genome engineering technology such as CRISPR technology and HIV using ZFN has impelled genome engineering companies to invest in advanced researches focusing on developing innovative techniques for genetic engineering.
Academics emerged as the second largest segment in terms of application. Studies and research programs being conducted by academic institutions regarding the use of genome engineering techniques to treat genetic disorders and produce mutants has helped in the progress of the segment. Thus, the academics segment is anticipated to maintain stable growth in the forecast period.
The leading players in the global genome engineering market are Inc., Sigma-Aldrich Corporation, Thermo Fisher Scientific, Sangamo Biosciences, Inc., Horizon Discovery Group Plc, Lonza Group Ltd., and Integrated DNA Technologies, Inc.
Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
Chapter 2 Executive Summary
2.1 Market Snapshot
Chapter 3 Global Genome Engineering Market– Industry Analysis
3.2 Market Drivers
3.2.1 Increased funding in Genomic research
3.2.2 Investment by Pharmaceutical Companies for developing new treatments
3.2.3 Rising demand for synthetic genes
3.3 Market Restraints
3.3.1 Ethical Issues
3.3.2 Stringent regulatory framework
3.3.3 Negative public perception related to genetic research
3.4.1 Technological improvements for wide range of applications
3.5 Porter’s Five Force Analysis of the Global Genome Engineering Market
3.5.1 Bargaining power of suppliers
3.5.2 Bargaining power of buyers
3.5.3 Threat of substitutes
3.5.4 Threat of new entrants
3.5.5 Competitive rivalry
3.6 Market Attractiveness Analysis: Global Genome Engineering Market, by Geography
3.7 Competitive Landscape
3.7.1 Market Share Analysis: Global Genome Engineering Market, 2014 (Value %)
Chapter 4 Global Genome Engineering Market, by Technology
4.1 Global Genome Engineering Market Revenue, by Technology, 2013–2023, (US$ Mn)
Chapter 5 Global Genome Engineering Market, by Application
5.1 Global Genome Engineering Market Revenue, By Application, 2013–2023, (US$ Mn)
Chapter 6 Global Genome Engineering Market, by End-User
6.1 Global Genome Engineering Market Revenue, By End-User, 2013–2023, (US$ Mn)
Chapter 7 Global Genome Engineering Market, by Geography
7.1 Global Genome Engineering Market Revenue, by Geography, 2013 – 2023 (USD Mn)
7.2 North America Genome Engineering Market Revenue, 2013 - 2023, (USD Mn)
7.3 Europe Genome Engineering Market Revenue, 2013 - 2023, (USD Mn)
7.4 Asia-Pacific Genome Engineering Market Revenue, 2013 - 2023, (US$ Mn)
7.5 Rest of World Genome Engineering Market Revenue, 2013 - 2023, (US$ Mn)
Chapter 8 Recommendations
Chapter 9 Company Profiles
9.1Applied StemCell, Inc.
9.1.1 Company Overview
9.1.2 Product Portfolio
9.1.3 Recent Developments
9.2 Horizon Discovery Group Plc
9.2.1 Company Overview
9.2.2 Financial Overview
9.2.3 Product Portfolio
9.2.4 Recent Developments
9.3 Sigma-Aldrich Corporation
9.3.1 Company Profile
9.3.3 Product Portfolio
9.3.3 Recent Developments
9.4 Genscript USA Inc.
9.4.1 Company Overview
9.4.2 Product Portfolio
9.4.3 Recent Developments
9.5 Sangamo Biosciences, Inc.
9.5.1 Company Overview
9.5.2 Financial Overview
9.5.3 Product Portfolio
9.5.4 Recent Developments
9.6 Integrated DNA Technologies, Inc
9.6.1 Company Overview
9.6.2 Financial Overview
9.6.3 Product Portfolio
9.6.4 Recent Developments
9.7 Lonza Group Ltd.
9.7.1 Company Overview
9.7.2 Financial Overview
9.7.3 Product Portfolio
9.7.4 Recent Developments
9.8 New England Biolabs, Inc.
9.8.1 Company Overview
9.8.2 Financial Overview
9.8.3 Product Portfolio
9.8.4 Recent Developments
9.9 Thermo Fisher Scientific, Inc
9.9.1 Company Overview
9.9.2 Financial Overview
9.9.4 Recent Developments
9.10 Origene Technologies, Inc.
9.10.1 Company Overview
9.10.2 Financial Overview
9.10.4 Recent Developments
9.11 Transposagen Biopharmaceuticals, Inc..
9.11.1 Company Overview
9.11.2 Financial Overview
9.11.4 Recent Developments
Genome engineering is the synthetic modification of chromosomal DNA by using molecular scissors. Current advances in genome engineering are based on the programmable nucleases that can modify eukaryotic genomes. The global genome engineering market report includes the current and future prospects of the market with an elaborate executive summary, including a market snapshot on various segments and sub-segments. This section also provides the overall information and data analysis of the global genome engineering market with respect to the leading market segments based on type of technology, application, end-user and geography.
The market overview section of the report includes qualitative analysis of the overall genome engineering market including the factors determining the market dynamics such as drivers, restraints and opportunities, along with Porter’s five forces analysis. In addition, various analyses such as market attractiveness analysis by geography and competitive landscape by key players has also been provided. The market attractiveness analysis explains the intensity of competition in the market in different geographies. The competitive scenario between different market players is evaluated through market share analysis. These factors would help the market players to take strategic decisions in order to strengthen their positions and expand their share in the global market.
The global genome engineering market has been segmented on the basis of technology, application, end-user and geography. Based on technology, the genome engineering market has been categorized into two major segments: Clustered regularly-interspaced short palindromic repeats (CRISPR), Transcription activator-like effector nuclease (TALEN), Zinc finger nuclease (ZFN) and other technologies, while the other technologies include antisense technology and recombinant AAV mediated genome engineering. Based on application, market has been segmented into Cell-line Engineering, Animal Genome Engineering, Plant genome engineering and Other Application. Based on end-user, the market is segmented into Pharmaceutical and Biotechnology Companies, Academics and Clinical Research Organizations. Market revenue in terms of USD million for the period between 2013 and 2023 along with the compound annual growth rate (CAGR %) from 2015 to 2023 are provided for all the segments, considering 2014 as the base year.
Geographically, the genome engineering market has been categorized into four regions: North America, Europe, Asia Pacific and Rest of the World (RoW). North America comprises the U.S. and Canada. Europe comprises Germany, the U.K., and Rest of Europe. Asia Pacific comprises China, India, and Rest of Asia Pacific. Rest of World comprises of Latin America, Middle-East & Africa. The recommendations section included in the report would assist existing players to expand their market share and new companies to establish their presence in the genome engineering market. The report also profiles major players in the genome engineering market on the basis of various attributes such as company overview, financial overview, business strategies, product portfolio, and recent developments. Major players profiled in this report include Thermo Fisher Scientific, Inc., Sigma-Aldrich Corporation, Sangamo Biosciences, Inc., Lonza Group Ltd., Horizon Discovery Group Plc, and Integrated DNA Technologies, Inc.
Global Genome Engineering Market, by Technology
- Clustered regularly interspaced short palindromic repeats (CRISPR)
- Transcription activator-like effector nuclease (TALEN)
- Zinc Finger Nuclease (ZFN)
- Other Technologies
Global Genome Engineering Market, by Application
- Cell Line Engineering
- Animal Genome Engineering
- Plant Genome Engineering
- Other Application
Global Genome Engineering Market, by End-User
- Pharmaceutical and Biotechnology Companies
- Clinical Research Organizations
Global Genome Engineering Market, by Geography
- North America
- Rest of Europe
- Asia Pacific
- Rest of Asia Pacific
- Rest of the World (RoW)
- Latin America
- Middle-East & Africa